Pharming Group Price/Book Ratio 2013-2024 | PHGUF

Related Stocks
Company Name	Market Cap
Amgen (AMGN)	$153.4B
Gilead Sciences (GILD)	$121.1B
Bristol Myers Squibb (BMY)	$119.6B
Vertex Pharmaceuticals (VRTX)	$118.9B
CSL (CSLLY)	$83.5B
Regeneron Pharmaceuticals (REGN)	$74B
GSK (GSK)	$73.1B
Argenex SE (ARGX)	$39.8B
Alnylam Pharmaceuticals (ALNY)	$35B
BioNTech SE (BNTX)	$29.7B
BeiGene (ONC)	$22B
Illumina (ILMN)	$21.1B
Biogen (BIIB)	$21B
Moderna (MRNA)	$15.2B
Incyte (INCY)	$14.3B
Insmed (INSM)	$13.7B
Intra-Cellular Therapies (ITCI)	$13.5B
Genmab (GNMSF)	$13B
Genmab (GMAB)	$13B
BioMarin Pharmaceutical (BMRN)	$12.1B
Bio-Techne Corp (TECH)	$11.7B
Vaxcyte (PCVX)	$11B
Sarepta Therapeutics (SRPT)	$10.9B
Swedish Orphan Biovitrum (BIOVF)	$10.9B
Exact Sciences (EXAS)	$10.4B
Bio-Rad Laboratories (BIO.B)	$10B
QIAGEN (QGEN)	$9.9B
Exelixis (EXEL)	$9.5B
Repligen (RGEN)	$9.3B
Roivant Sciences (ROIV)	$8.1B

No results found